AXCELLA HEALTH INC's ticker is AXLA and the CUSIP is 05454B105. A total of 1 filers reported holding AXCELLA HEALTH INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $67 | -94.6% | 308 | -88.1% | 0.00% | – |
| Q1 2023 | $1,246 | +46.9% | 2,595 | +0.2% | 0.00% | – |
| Q4 2022 | $848 | -57.6% | 2,591 | +79.6% | 0.00% | – |
| Q3 2022 | $2,000 | -33.3% | 1,443 | -4.3% | 0.00% | – |
| Q2 2022 | $3,000 | 0.0% | 1,508 | +36.3% | 0.00% | – |
| Q1 2022 | $3,000 | 0.0% | 1,106 | -21.3% | 0.00% | – |
| Q4 2021 | $3,000 | 0.0% | 1,405 | +27.1% | 0.00% | – |
| Q3 2021 | $3,000 | -25.0% | 1,105 | -0.8% | 0.00% | – |
| Q2 2021 | $4,000 | -85.7% | 1,114 | -81.0% | 0.00% | – |
| Q1 2021 | $28,000 | -73.8% | 5,858 | -71.4% | 0.00% | – |
| Q4 2020 | $107,000 | +40.8% | 20,507 | +24.6% | 0.00% | – |
| Q3 2020 | $76,000 | -22.4% | 16,455 | -6.2% | 0.00% | – |
| Q2 2020 | $98,000 | +145.0% | 17,543 | +48.2% | 0.00% | – |
| Q1 2020 | $40,000 | +1900.0% | 11,838 | +1558.0% | 0.00% | – |
| Q4 2019 | $2,000 | +100.0% | 714 | +281.8% | 0.00% | – |
| Q3 2019 | $1,000 | – | 187 | +1000.0% | 0.00% | – |
| Q2 2019 | $0 | – | 17 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HARBOURVEST PARTNERS LLC | 2,807,981 | $14,573,000 | 5.70% |
| Flagship Pioneering Inc. | 12,548,414 | $65,126,000 | 1.19% |
| Artal Group S.A. | 712,500 | $3,698,000 | 0.08% |
| GSA CAPITAL PARTNERS LLP | 30,713 | $159,000 | 0.03% |
| ZACKS INVESTMENT MANAGEMENT | 132,915 | $690,000 | 0.01% |
| Virtu Financial LLC | 15,682 | $81,000 | 0.01% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 187,122 | $971,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 62,467 | $324,000 | 0.01% |
| FMR LLC | 5,631,132 | $29,226,000 | 0.00% |
| MARSHALL WACE, LLP | 60,307 | $313,000 | 0.00% |